title: Commission Implementing Regulation (EU) 2021/11 of 7 January 2021 amending Implementing Regulation (EU) No 498/2012 on the allocation of tariff-rate quotas applying to exports of wood from the Russian Federation to the European Union

text:
                  8.1.2021

                  EN

                  Official Journal of the European Union

                  L 5/1

         COMMISSION IMPLEMENTING REGULATION (EU) 2021/11
         of 7 January 2021
         amending Implementing Regulation (EU) No 498/2012 on the allocation of tariff-rate quotas applying to exports of wood from the Russian Federation to the European Union
         THE EUROPEAN COMMISSION,
         Having regard to the Treaty on the Functioning of the European Union,
         Having regard to Council Decision 2012/105/EU of 14 December 2011 on the signing, on behalf of the Union, and provisional application of the Agreement in the form of an Exchange of Letters between the European Union and the Russian Federation relating to the administration of tariff-rate quotas applying to exports of wood from the Russian Federation to the European Union and the Protocol between the European Union and the Government of the Russian Federation on technical modalities pursuant to that Agreement (1), and in particular Article 4 thereof,
         Whereas:

                     (1)

                     On 22 August 2012, the Russian Federation acceded to the World Trade Organization. The commitments of the Russian Federation include tariff-rate quotas for the export of specified types of coniferous wood, a share of which has been allocated for exports to the Union. The modalities for the administration of those tariff-rate quotas are laid down in the Agreement in the form of an Exchange of Letters between the European Union and the Russian Federation relating to the administration of tariff-rate quotas applying to exports of wood from the Russian Federation to the European Union (2) (‘the Agreement’) and in the Protocol between the European Union and the Government of the Russian Federation on technical modalities pursuant to the Agreement (3) (‘the Protocol’). The Agreement and the Protocol were signed on 16 December 2011. They have been applied provisionally from the date of the accession of the Russian Federation to the World Trade Organization.

                     (2)

                     Pursuant to Article 4 of Decision 2012/105/EU, Commission Implementing Regulation (EU) No 498/2012 (4) laid down the rules on the allocation of tariff-rate quotas applying to exports of wood from the Russian Federation to the European Union. That Regulation will cease to apply on the date on which the procedure for the conclusion of the Protocol is completed.

                     (3)

                     While the Agreement and the Protocol continue to be applied provisionally, pending the completion of the procedures for their conclusion, the experience gained with the implementation of Implementing Regulation (EU) No 498/2012 has revealed the need to amend some provisions of that Regulation.

                     (4)

                     Article 7(1) of Implementing Regulation (EU) No 498/2012 should be amended in order to ensure that in the first part of each quota period the maximum import rights of traditional importers, for any of the product groups, are not lower than those granted to new importers.

                     (5)

                     Pursuant to Article 3 of the Protocol, the classification of the covered products is based on the tariff and statistical nomenclature applied in Russia. Annexes I and III to Implementing Regulation (EU) No 498/2012 refer to the relevant tariff codes of the covered products. Considering that the nomenclature has been modified since the Protocol has applied provisionally, there is a need to reflect these modifications in the Annexes to reflect the tariff and statistical nomenclature currently applied in the Russian Federation. Annexes I and III should therefore be amended accordingly.

                     (6)

                     The measures provided for in this Regulation are in accordance with the opinion of the Wood Committee established by Decision 2012/105/EU,

               HAS ADOPTED THIS REGULATION:

            Article 1
            Implementing Regulation (EU) No 498/2012 is amended as follows:

                        (1)

                        in Article 2, the second paragraph is replaced by the following:
                        ‘In addition, the following definition shall apply: “product group” means each of the two categories of covered products according to the classification of such products under the tariff and statistical nomenclature applied in the Russian Federation, namely spruce and pine. The relevant tariff codes applied in the Russian Federation and corresponding Combined Nomenclature (*1) (“CN”) and TARIC codes are attached as Annex I.

                           (*1)  Currently falling within Commission Regulation (EU) 2019/1776 (OJ L 280, 31.10.2019, p. 1.)’;"

                        (2)

                        in Article 7, paragraph 1 is replaced by the following:

                           ‘1.   Every year, the Commission shall calculate ceilings applicable to each traditional importer for the following quota period in accordance with the method established in Article 6(2). If the calculated ceiling of a traditional importer for a given product group is below the maximum of 1,5 % of the tariff quota granted to new importers in accordance with Article 4(3), the ceiling of the traditional importer concerned shall be established at a level of 1,5 % of the tariff quota for the respective product group.’;

                        (3)

                        Annex I is replaced by the text in Annex I to this Regulation;

                        (4)

                        Annex III is replaced by the text in Annex II to this Regulation.

            Article 2
            This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union

            This Regulation shall be binding in its entirety and directly applicable in all Member States.
            Done at Brussels, 7 January 2021.

                  For the Commission

                  The President

               Ursula VON DER LEYEN

            (1)  OJ L 57, 29.2.2012, p. 1.

            (2)  OJ L 57, 29.2.2012, p. 3.

            (3)  OJ L 57, 29.2.2012, p. 5.

            (4)  Commission Implementing Regulation (EU) No 498/2012 of 12 June 2012 on the allocation of tariff-rate quotas applying to exports of wood from the Russian Federation to the European Union (OJ L 152, 13.6.2012, p. 28).

            ANNEX I

                     ‘ANNEX I
                     Relevant tariff codes applied in the Russian Federation and corresponding CN and TARIC codes as referred to in Article 2

                                    CN code

                                    TARIC code

                                    Russian Tariff code

                                    Full description

                                 1.

                                 ex 4403 23 10

                                 10

                                 4403 23 110 0

                                 Timber of spruce of the kind Picea abies Karst. or silver fir (Abies alba Mill.), of a diameter of no less than 15 cm but no more than 24 cm, of a length of no less than 1,0 m

                                 ex 4403 23 90

                                 10

                                 4403 23 190 0

                                 2.

                                 ex 4403 23 10

                                 10

                                 4403 23 110 0

                                 Timber of spruce of the kind Picea abies Karst. or silver fir (Abies alba Mill.), of a diameter of more than 24 cm, of a length of no less than 1,0 m

                                 ex 4403 23 90

                                 10

                                 4403 23 190 0

                                 3.

                                 ex 4403 24 00

                                 10

                                 4403 24 100 0

                                 Wood of spruce of the kind Picea abies Karst. or silver fir (Abies alba Mill.) in the rough, whether or not stripped of bark or sapwood, or roughly squared, of a diameter of less than 15 cm

                                 4.

                                 ex 4403 24 00

                                 10

                                 4403 24 100 0

                                 Other wood of spruce of the kind Picea abies Karst. or silver fir (Abies alba Mill.)

                                 5.

                                 ex 4403 21 10

                                 10

                                 4403 21 110 0

                                 Timber of pine of the kind Pinus sylvestris L., of a diameter of no less than 15 cm but no more than 24 cm, of a length of no less than 1,0 m

                                 ex 4403 21 90

                                 10

                                 4403 21 190 0

                                 6.

                                 ex 4403 21 10

                                 10

                                 4403 21 110 0

                                 Timber of pine of the kind Pinus sylvestris L., of a diameter of more than 24 cm, of a length of no less than 1,0 m

                                 ex 4403 21 90

                                 10

                                 4403 21 190 0

                                 7.

                                 ex 4403 22 00

                                 10

                                 4403 22 100 0

                                 Wood of pine of the kind Pinus sylvestris L. (in the rough, whether or not stripped of bark or sapwood, or roughly squared) of a diameter of less than 15 cm

                                 8.

                                 ex 4403 22 00

                                 10

                                 4403 22 100 0

                                 Other wood of pine of the kind Pinus sylvestris L.

               ’

            ANNEX II

                     ‘ANNEX III
                     Correction coefficients referred to in Article 11(2)

                                    Russian Tariff code

                                    Correction coefficient

                                 4403231100
                                 4403231900
                                 4403241000

                                 0,88

                                 4403211100
                                 4403211900
                                 4403221000

                                 0,87

               ’


title: Commission Implementing Regulation (EU) 2021/51 of 22 January 2021 authorising a change of the conditions of use of the novel food ‘trans-resveratrol’ under Regulation (EU) 2015/2283 of the European Parliament and of the Council and amending Commission Implementing Regulation (EU) 2017/2470 (Text with EEA relevance)

text:
                  25.1.2021

                  EN

                  Official Journal of the European Union

                  L 23/10

         COMMISSION IMPLEMENTING REGULATION (EU) 2021/51
         of 22 January 2021
         authorising a change of the conditions of use of the novel food ‘trans-resveratrol’ under Regulation (EU) 2015/2283 of the European Parliament and of the Council and amending Commission Implementing Regulation (EU) 2017/2470
         (Text with EEA relevance)
         THE EUROPEAN COMMISSION,
         Having regard to the Treaty on the Functioning of the European Union,
         Having regard to Regulation (EU) 2015/2283 of the European Parliament and of the Council of 25 November 2015 on novel foods, amending Regulation (EU) No 1169/2011 of the European Parliament and of the Council and repealing Regulation (EC) No 258/97 of the European Parliament and of the Council and Commission Regulation (EC) No 1852/2001 (1), and in particular Article 12 thereof,
         Whereas:

                     (1)

                     Regulation (EU) 2015/2283 provides that only novel foods authorised and included in the Union list may be placed on the market within the Union.

                     (2)

                     Pursuant to Article 8 of Regulation (EU) 2015/2283, Commission Implementing Regulation (EU) 2017/2470 (2) establishing a Union list of authorised novel foods was adopted.

                     (3)

                     Commission Implementing Decision (EU) 2016/1190 (3) authorised the placing on the Union market of trans-resveratrol as a novel food ingredient under Regulation (EC) No 258/97 of the European Parliament and of the Council (4), to be used in food supplements as defined in Directive 2002/46/EC of the European Parliament and of the Council (5), in capsule or tablet form, for the adult population.

                     (4)

                     On 31 January 2020, the company DSM Nutritional Products Europe (‘the applicant’) submitted an application to the Commission in accordance with Article 10(1) of Regulation (EU) 2015/2283 to change the conditions of use of the novel food ‘trans-resveratrol’. The applicant requested the modification of the delivery formats for food supplements containing the novel food trans-resveratrol, in particular removing the specific delivery formats, capsule or tablet form, as the only allowed forms of the food supplements as listed in the Union list.

                     (5)

                     The applicant considers that the modification of the delivery formats for food supplements containing trans-resveratrol is necessary, as it would allow trans-resveratrol to be used in other food supplement forms than capsules or tablets.

                     (6)

                     There are a number of novel foods currently authorised in food supplements and listed in the Union list of novel foods for which the delivery formats have not been specified. Therefore, the modification of the delivery formats for food supplements containing trans-resveratrol would ensure consistency regarding the conditions of use of food supplements, as well as provide more options to food business operators to follow consumer preferences.

                     (7)

                     The Commission did not request an opinion from the European Food Safety Authority in accordance with Article 10(3) as the change of the conditions of use of the novel food trans-resveratrol by removing the specific delivery formats of food supplements is not liable to have an effect on human health. Therefore, it is appropriate to change the conditions of use of the novel food trans-resveratrol to authorise its use in any form of food supplements at the previously authorised maximum level.

                     (8)

                     The maximum level of trans-resveratrol in food supplements authorised by Implementing Decision (EU) 2016/1190 and indicated in the Union list of novel foods remains the same. The safety considerations that supported the authorisation of trans-resveratrol in food supplements remain valid and the removal of the specific delivery formats of food supplements does not pose safety concern.

                     (9)

                     The Annex to Implementing Regulation (EU) 2017/2470 should therefore be amended accordingly.

                     (10)

                     The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed,

               HAS ADOPTED THIS REGULATION:

            Article 1

               1.   The entry in the Union list of authorised novel foods as provided for in Article 6 of Regulation (EU) 2015/2283 and included in Implementing Regulation (EU) 2017/2470, referring to the ‘trans-resveratrol’, shall be amended as specified in the Annex to this Regulation.

               2.   The entry in the Union list referred to in paragraph 1 shall include the conditions of use and labelling requirements laid down in the Annex.

            Article 2
            This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.

            This Regulation shall be binding in its entirety and directly applicable in all Member States.
            Done at Brussels, 22 January 2021.

                  For the Commission

                  The President

               Ursula VON DER LEYEN

            (1)  OJ L 327, 11.12.2015, p. 1.

            (2)  Commission Implementing Regulation (EU) 2017/2470 of 20 December 2017 establishing the Union list of novel foods in accordance with Regulation (EU) 2015/2283 of the European Parliament and of the Council on novel foods (OJ L 351, 30.12.2017, p. 72).

            (3)  Commission Implementing Decision (EU) 2016/1190 of 19 July 2016 authorising the placing on the market of trans-resveratrol as a novel food ingredient under Regulation (EC) No 258/97 of the European Parliament and of the Council (OJ L 196, 21.7.2016, p. 53).

            (4)  Regulation (EC) No 258/97 of the European Parliament and of the Council of 27 January 1997 concerning novel foods and novel food ingredients (OJ L 43, 14.2.1997, p. 1).

            (5)  Directive 2002/46/EC of the European Parliament and of the Council of 10 June 2002 on the approximation of the laws of the Member States relating to food supplements (OJ L 183, 12.7.2002, p. 51).

            ANNEX
            In the Annex to Implementing Regulation (EU) 2017/2470, the entry for ‘Trans-resveratrol’ in Table 1 (Authorised novel foods) is replaced by the following:

                           Authorised novel food

                           Conditions under which the novel food may be used

                           Additional specific labelling requirements

                           Other requirements

                           Data protection

                           ‘Trans-resveratrol

                              Specified food category

                              Maximum levels

                                       1.

                                       The designation of the novel food on the labelling of the food supplements containing it shall be “Trans-resveratrol”.

                                       2.

                                       The labelling of food supplements containing trans-resveratrol shall bear a statement that people using medicines should only consume the product under medical supervision.’

                           Food supplements as defined in Directive 2002/46/EC for the adult population

                           150 mg/day


title: Commission Implementing Regulation (EU) 2021/52 of 22 January 2021 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances benfluralin, dimoxystrobin, fluazinam, flutolanil, mecoprop-P, mepiquat, metiram, oxamyl and pyraclostrobin (Text with EEA relevance)

text:
                  25.1.2021

                  EN

                  Official Journal of the European Union

                  L 23/13

         COMMISSION IMPLEMENTING REGULATION (EU) 2021/52
         of 22 January 2021
         amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances benfluralin, dimoxystrobin, fluazinam, flutolanil, mecoprop-P, mepiquat, metiram, oxamyl and pyraclostrobin
         (Text with EEA relevance)
         THE EUROPEAN COMMISSION,
         Having regard to the Treaty on the Functioning of the European Union,
         Having regard to Regulation (EC) No 1107/2009 of the European Parliament and of the Council of 21 October 2009 concerning the placing of plant protection products on the market and repealing Council Directives 79/117/EEC and 91/414/EEC (1), and in particular the first paragraph of Article 17 thereof,
         Whereas:

                     (1)

                     Part A of the Annex to Commission Implementing Regulation (EU) No 540/2011 (2) sets out the active substances deemed to have been approved under Regulation (EC) No 1107/2009.

                     (2)

                     Commission Implementing Regulation (EU) 2019/2094 (3) extended the approval period of the active substances dimoxystrobin, mecoprop-P, metiram, oxamyl and pyraclostrobin until 31 January 2021, and the approval period of the active substances benfluralin, fluazinam, flutolanil and mepiquat until 28 February 2021.

                     (3)

                     Applications for the renewal of the approval of those substances were submitted in accordance with Commission Implementing Regulation (EU) No 844/2012 (4).

                     (4)

                     Due to the fact that the assessment of those substances has been delayed for reasons beyond the control of the applicants, the approvals of those active substances are likely to expire before a decision has been taken on their renewal. It is therefore necessary to extend their approval periods.

                     (5)

                     Furthermore, an extension of the approval period is required for the active substances flutolanil, mepiquat and pyraclostrobin to allow the time necessary to carry out an assessment relating to endocrine disrupting properties of those active substances in accordance with the procedure set out in Articles 13 and 14 of Implementing Regulation (EU) No 844/2012.

                     (6)

                     As regards cases where the Commission is to adopt a Regulation providing that the approval of an active substance referred to in the Annex to this Regulation is not renewed because the approval criteria are not satisfied, the Commission is to set the expiry date at the same date as before this Regulation or at the date of the entry into force of the Regulation providing that the approval of the active substance is not renewed, whichever date is later. As regards cases where the Commission is to adopt a Regulation providing for the renewal of an active substance referred to in the Annex to this Regulation, the Commission will endeavour to set, as appropriate under the circumstances, the earliest possible application date.

                     (7)

                     Implementing Regulation (EU) No 540/2011 should therefore be amended accordingly.

                     (8)

                     The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed,

               HAS ADOPTED THIS REGULATION:

            Article 1
            The Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation.

            Article 2
            This Regulation shall enter into force on the day following that of its publication in the Official Journal of the European Union.

            This Regulation shall be binding in its entirety and directly applicable in all Member States.
            Done at Brussels, 22 January 2021.

                  For the Commission

                  The President

               Ursula VON DER LEYEN

            (1)  OJ L 309, 24.11.2009, p. 1.

            (2)  Commission Implementing Regulation (EU) No 540/2011 of 25 May 2011 implementing Regulation (EC) No 1107/2009 of the European Parliament and of the Council as regards the list of approved active substances (OJ L 153, 11.6.2011, p. 1).

            (3)  Commission implementing Regulation (EU) 2019/2094 of 29 November 2019 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances benfluralin, dimoxystrobin, fluazinam, flutolanil, mancozeb, mecoprop-P, mepiquat, metiram, oxamyl and pyraclostrobin (OJ L 317, 9.12.2019, p. 102).

            (4)  Commission Implementing Regulation (EU) No 844/2012 of 18 September 2012 setting out the provisions necessary for the implementation of the renewal procedure for active substances, as provided for in Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market (OJ L 252, 19.9.2012, p. 26).

            ANNEX
            Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows:

                        (1)

                        in the sixth column, expiration of approval, of row 57, Mecoprop-P, the date is replaced by ‘31 January 2022’;

                        (2)

                        in the sixth column, expiration of approval, of row 81, Pyraclostrobin, the date is replaced by ‘31 January 2022’;

                        (3)

                        in the sixth column, expiration of approval, of row 115, Metiram, the date is replaced by ‘31 January 2022’;

                        (4)

                        in the sixth column, expiration of approval, of row 116, Oxamyl, the date is replaced by ‘31 January 2022’;

                        (5)

                        in the sixth column, expiration of approval, of row 128, Dimoxystrobin, the date is replaced by ‘31 January 2022’;

                        (6)

                        in the sixth column, expiration of approval, of row 187, Flutolanil, the date is replaced by ‘28 February 2022’;

                        (7)

                        in the sixth column, expiration of approval, of row 188, Benfluralin, the date is replaced by ‘28 February 2022’;

                        (8)

                        in the sixth column, expiration of approval, of row 189, Fluazinam, the date is replaced by ‘28 February 2022’;

                        (9)

                        in the sixth column, expiration of approval, of row 191, Mepiquat, the date is replaced by ‘28 February 2022’.


title: Commission Implementing Regulation (EU) 2021/53 of 22 January 2021 amending Council Regulation (EC) No 1210/2003 concerning certain specific restrictions on economic and financial relations with Iraq

text:
                  25.1.2021

                  EN

                  Official Journal of the European Union

                  L 23/16

         COMMISSION IMPLEMENTING REGULATION (EU) 2021/53
         of 22 January 2021
         amending Council Regulation (EC) No 1210/2003 concerning certain specific restrictions on economic and financial relations with Iraq
         THE EUROPEAN COMMISSION,
         Having regard to the Treaty on the Functioning of the European Union,
         Having regard to Council Regulation (EC) No 1210/2003 of 7 July 2003 concerning certain specific restrictions on economic and financial relations with Iraq and repealing Regulation (EC) No 2465/96 (1), and in particular Article 11(b) thereof,
         Whereas:

                     (1)

                     Annex IV to Regulation (EC) No 1210/2003 lists natural and legal persons, bodies or entities associated with the regime of former President Saddam Hussein covered by the freezing of funds and economic resources and by a prohibition to make funds or economic resources available.

                     (2)

                     On 18 January 2021, the Sanctions Committee of the United Nations Security Council decided to remove two persons from the list of persons and entities to whom the freezing of funds and economic resources should apply.

                     (3)

                     Annex IV to Regulation (EC) No 1210/2003 should therefore be amended accordingly,

               HAS ADOPTED THIS REGULATION:

            Article 1
            Annex IV to Regulation (EC) No 1210/2003 is amended as set out in the Annex to this Regulation.

            Article 2
            This Regulation shall enter into force on the day following that of its publication in the Official Journal of the European Union.

            This Regulation shall be binding in its entirety and directly applicable in all Member States.
            Done at Brussels, 22 January 2021.

                  For the Commission,

                  On behalf of The President,

                  Director-General

                  Directorate-General for Financial Stability, Financial Services and Capital Markets Union

            (1)  OJ L 169, 8.7.2003, p. 6.

            ANNEX
            In Annex IV to Regulation (EC) No 1210/2003, the following entries are deleted:

                        ‘31.

                        NAME: Zuhair Talib Abd-al-Sattar Al-Naqib. DATE OF BIRTH/PLACE OF BIRTH: Circa 1948. NATIONALITY: Iraq. UNSC RESOLUTION 1483 BASIS: Director, Military Intelligence.’

                        ‘33.

                        NAME: Amir Rashid Muhammad Al-Ubaidi. DATE OF BIRTH/PLACE OF BIRTH: 1939, Baghdad. NATIONALITY: Iraq. UNSC RESOLUTION 1483 BASIS: Minister of Oil, 1996 to 2003; Head, Organisation of Military Industrialisation, early 1990s.’


title: Council Implementing Regulation (EU) 2021/707 of 29 April 2021 implementing Article 17(3) of Regulation (EU) No 224/2014 concerning restrictive measures in view of the situation in the Central African Republic

text:
                  30.4.2021

                  EN

                  Official Journal of the European Union

                  L 147/3

         COUNCIL IMPLEMENTING REGULATION (EU) 2021/707
         of 29 April 2021
         implementing Article 17(3) of Regulation (EU) No 224/2014 concerning restrictive measures in view of the situation in the Central African Republic
         THE COUNCIL OF THE EUROPEAN UNION,
         Having regard to the Treaty on the Functioning of the European Union,
         Having regard to Council Regulation (EU) No 224/2014 of 10 March 2014 concerning restrictive measures in view of the situation in the Central African Republic (1), and in particular Article 17(3) thereof,
         Having regard to the proposal from the High Representative of the Union for Foreign Affairs and Security Policy,
         Whereas:

                     (1)

                     On 10 March 2014, the Council adopted Regulation (EU) No 224/2014.

                     (2)

                     On 5 April 2021, the United Nations Security Council (UNSC) Committee established pursuant to UNSC Resolution 2127 (2013) approved the removal of one entity from the list of persons and entities subject to restrictive measures.

                     (3)

                     Annex I to Regulation (EU) No 224/2014 should therefore be amended accordingly,

               HAS ADOPTED THIS REGULATION:

            Article 1
            Annex I to Regulation (EU) No 224/2014 is hereby amended as set out in the Annex to this Regulation.

            Article 2
            This Regulation shall enter into force on the day of its publication in the Official Journal of the European Union.

            This Regulation shall be binding in its entirety and directly applicable in all Member States.
            Done at Brussels, 29 April 2021.

                  For the Council

                  The President

               A. P. ZACARIAS

            (1)  OJ L 70, 11.3.2014, p. 1.

            ANNEX
            In the list set out in Part B (Entities) of Annex I to Regulation (EU) No 224/2014, the entry for the following entity is deleted:

                        1.

                           Bureau d’achat de diamant en Centrafrique/Kardiam (alias: a) Badica/Krdiam b) Kardiam).


title: Commission Implementing Regulation (EU) 2021/745 of 6 May 2021 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances aluminium ammonium sulphate, aluminium silicate, beflubutamid, benthiavalicarb, bifenazate, boscalid, calcium carbonate, captan, carbon dioxide, cymoxanil, dimethomorph, ethephon, extract from tea tree, famoxadone, fat distilation residues, fatty acids C7 to C20, flumioxazine, fluoxastrobin, flurochloridone, folpet, formetanate, gibberellic acid, gibberellins, heptamaloxyloglucan, hydrolysed proteins, iron sulphate, metazachlor, metribuzin, milbemectin, Paecilomyces lilacinus strain 251, phenmedipham, phosmet, pirimiphos-methyl, plant oils/rape seed oil, potassium hydrogen carbonate, propamocarb, prothioconazole, quartz sand, fish oil, repellents by smell of animal or plant origin/ sheep fat, S-metolachlor, Straight Chain Lepidopteran Pheromones, tebuconazole and urea (Text with EEA relevance)

text:
                  7.5.2021

                  EN

                  Official Journal of the European Union

                  L 160/89

         COMMISSION IMPLEMENTING REGULATION (EU) 2021/745
         of 6 May 2021
         amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances aluminium ammonium sulphate, aluminium silicate, beflubutamid, benthiavalicarb, bifenazate, boscalid, calcium carbonate, captan, carbon dioxide, cymoxanil, dimethomorph, ethephon, extract from tea tree, famoxadone, fat distilation residues, fatty acids C7 to C20, flumioxazine, fluoxastrobin, flurochloridone, folpet, formetanate, gibberellic acid, gibberellins, heptamaloxyloglucan, hydrolysed proteins, iron sulphate, metazachlor, metribuzin, milbemectin, Paecilomyces lilacinus strain 251, phenmedipham, phosmet, pirimiphos-methyl, plant oils/rape seed oil, potassium hydrogen carbonate, propamocarb, prothioconazole, quartz sand, fish oil, repellents by smell of animal or plant origin/ sheep fat, S-metolachlor, Straight Chain Lepidopteran Pheromones, tebuconazole and urea
         (Text with EEA relevance)
         THE EUROPEAN COMMISSION,
         Having regard to the Treaty on the Functioning of the European Union,
         Having regard to Regulation (EC) No 1107/2009 of the European Parliament and of the Council of 21 October 2009 concerning the placing of plant protection products on the market and repealing Council Directives 79/117/EEC and 91/414/EEC (1), and in particular the first paragraph of Article 17 thereof,
         Whereas:

                     (1)

                     Part A of the Annex to Commission Implementing Regulation (EU) No 540/2011 (2) sets out the active substances deemed to have been approved under Regulation (EC) No 1107/2009.

                     (2)

                     Commission Implementing Regulation (EU) 2020/869 (3) extended the approval period of the active substances famoxadone and flumioxazine until 30 June 2021 and of the active substances beflubutamid, benthiavalicarb, bifenazate, boscalid, captan, dimethomorph, ethephon, fluoxastrobin, folpet, formetanate, metribuzin, milbemectin, Paecilomyces lilacinus strain 251, phenmedipham, phosmet, pirimiphos-methyl, propamocarb, prothioconazole, S-metolachlor until 31 July 2021. Commission Implementing Regulation (EU) 2020/1160 (4) extended the approval period of the active substances aluminium ammonium sulphate, aluminium silicate, calcium carbonate, carbon dioxide, extract from tea tree, fat distillation residues, fatty acids C7 to C20, gibberellic acid, gibberellins, hydrolysed proteins, iron sulphate, plant oils/rape seed oil, potassium hydrogen carbonate, quartz sand, fish oil, repellents by smell of animal or plant origin/sheep fat, Straight Chain Lepidopteran Pheromones, tebuconazole and urea until 31 August 2021. Commission Implementing Regulation (EU) 2017/195 (5) extended the approval period of the active substances metazachlor and cymoxanil until 31 July 2021 and 31 August 2021, respectively. Commission Implementing Regulation (EU) 2017/1527 (6) extended the approval period of the active substance heptamaloxyloglucan until 31 May 2021.

                     (3)

                     The approval of the active substance flurochloridone is set to expire on 31 May 2021 in accordance with Commission Directive 2011/34/EU (7).

                     (4)

                     Applications for the renewal of the approval of those substances were submitted in accordance with Commission Implementing Regulation (EU) No 844/2012 (8).

                     (5)

                     Due to the fact that the assessment of those active substances has been delayed for reasons beyond the control of the applicants, the approvals of those active substances are likely to expire before a decision has been taken on their renewal. It is therefore necessary to extend their approval periods.

                     (6)

                     In addition, an extension of the approval period is required for the active substances benthiavalicarb, calcium carbonate, dimethomorph, ethephon, fluoxastrobin, folpet, formetanate, gibberellic acid, gibberellins, metribuzin, milbemectin, phenmedipham, pirimiphos-methyl, propamocarb, prothioconazole, S-metolachlor, Straight Chain Lepidopteran Pheromones, tebuconazole and urea to provide the time necessary to carry out an assessment relating to endocrine disrupting properties of those active substances in accordance with the procedure set out in Articles 13 and 14 of Implementing Regulation (EU) No 844/2012.

                     (7)

                     As regards cases where the Commission is to adopt a Regulation providing that the approval of an active substance referred to in the Annex to this Regulation is not renewed because the approval criteria are not satisfied, the Commission is to set the expiry date at the same date as before this Regulation or at the date of the entry into force of the Regulation providing that the approval of the active substance is not renewed, whichever date is later. As regards cases where the Commission is to adopt a Regulation providing for the renewal of an active substance referred to in the Annex to this Regulation, the Commission will endeavour to set, as appropriate under the circumstances, the earliest possible application date.

                     (8)

                     Implementing Regulation (EU) No 540/2011 should therefore be amended accordingly.

                     (9)

                     The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed,

               HAS ADOPTED THIS REGULATION:

            Article 1
            The Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation.

            Article 2
            This Regulation shall enter into force on the third day following that of its publication in the Official Journal of the European Union.

            This Regulation shall be binding in its entirety and directly applicable in all Member States.
            Done at Brussels, 6 May 2021.

                  For the Commission

                  The President

               Ursula VON DER LEYEN

            (1)  OJ L 309, 24.11.2009, p. 1.

            (2)  Commission Implementing Regulation (EU) No 540/2011 of 25 May 2011 implementing Regulation (EC) No 1107/2009 of the European Parliament and of the Council as regards the list of approved active substances (OJ L 153, 11.6.2011, p. 1).

            (3)  Commission Implementing Regulation (EU) 2020/869 of 24 June 2020 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances beflubutamid, benalaxyl, benthiavalicarb, bifenazate, boscalid, bromoxynil, captan, cyazofamid, dimethomorph, ethephon, etoxazole, famoxadone, fenamiphos, flumioxazine, fluoxastrobin, folpet, formetanate, metribuzin, milbemectin, Paecilomyces lilacinus strain 251, phenmedipham, phosmet, pirimiphos-methyl, propamocarb, prothioconazole and S-metolachlor (OJ L 201, 25.6.2020, p. 7).

            (4)  Commission Implementing Regulation (EU) 2020/1160 of 5 August 2020 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances aluminium ammonium sulphate, aluminium silicate, blood meal, calcium carbonate, carbon dioxide, extract from tea tree, fat distillation residues, fatty acids C7 to C20, garlic extract, gibberellic acid, gibberellins, hydrolysed proteins, iron sulphate, kieselgur (diatomaceous earth), plant oils/rape seed oil, potassium hydrogen carbonate, quartz sand, fish oil, repellents by smell of animal or plant origin/sheep fat, Straight Chain Lepidopteran Pheromones, tebuconazole and urea (OJ L 257, 6.8.2020, p. 29).

            (5)  Commission Implementing Regulation (EU) 2017/195 of 3 February 2017 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of several active substances listed in Part B of the Annex to Implementing Regulation (EU) No 686/2012 (AIR IV renewal programme) (OJ L 31, 4.2.2017, p. 21).

            (6)  Commission Implementing Regulation (EU) 2017/1527 of 6 September 2017 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances cyflufenamid, fluopicolide, heptamaloxyloglucan and malathion (OJ L 231, 7.9.2017, p. 3).

            (7)  Commission Directive 2011/34/EU of 8 March 2011 amending Council Directive 91/414/EEC to include flurochloridone as active substance and amending Commission Decision 2008/934/EC (OJ L 62, 9.3.2011, p. 27).

            (8)  Commission Implementing Regulation (EU) No 844/2012 of 18 September 2012 setting out the provisions necessary for the implementation of the renewal procedure for active substances, as provided for in Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market (OJ L 252, 19.9.2012, p. 26).

            ANNEX
            Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows:

                        (1)

                        in the sixth column, expiration of approval, of row 35, Famoxadone, the date is replaced by ‘30 June 2022’;

                        (2)

                        in the sixth column, expiration of approval, of row 39, Flumioxazine, the date is replaced by ‘30 June 2022’;

                        (3)

                        in the sixth column, expiration of approval, of row 88, Phenmedipham, the date is replaced by ‘31 July 2022’;

                        (4)

                        in the sixth column, expiration of approval, of row 97, S-metolachlor, the date is replaced by ‘31 July 2022’;

                        (5)

                        in the sixth column, expiration of approval, of row 109, Bifenazate, the date is replaced by ‘31 July 2022’;

                        (6)

                        in the sixth column, expiration of approval, of row 110, Milbemectin, the date is replaced by ‘31 July 2022’;

                        (7)

                        in the sixth column, expiration of approval, of row 142, Ethephon, the date is replaced by ‘31 July 2022’;

                        (8)

                        in the sixth column, expiration of approval, of row 145, Captan, the date is replaced by ‘31 July 2022’;

                        (9)

                        in the sixth column, expiration of approval, of row 146, Folpet, the date is replaced by ‘31 July 2022’;

                        (10)

                        in the sixth column, expiration of approval, of row 147, Formetanate, the date is replaced by ‘31 July 2022’;

                        (11)

                        in the sixth column, expiration of approval, of row 150, Dimethomorph, the date is replaced by ‘31 July 2022’;

                        (12)

                        in the sixth column, expiration of approval, of row 152, Metribuzin, the date is replaced by ‘31 July 2022’;

                        (13)

                        in the sixth column, expiration of approval, of row 153, Phosmet, the date is replaced by ‘31 July 2022’;

                        (14)

                        in the sixth column, expiration of approval, of row 154, Propamocarb, the date is replaced by ‘31 July 2022’;

                        (15)

                        in the sixth column, expiration of approval, of row 156, Pirimiphos-methyl, the date is replaced by ‘31 July 2022’;

                        (16)

                        in the sixth column, expiration of approval, of row 158, Beflubutamid, the date is replaced by ‘31 July 2022’;

                        (17)

                        in the sixth column, expiration of approval, of row 163, Benthiavalicarb, the date is replaced by ‘31 July 2022’;

                        (18)

                        in the sixth column, expiration of approval, of row 164, Boscalid, the date is replaced by ‘31 July 2022’;

                        (19)

                        in the sixth column, expiration of approval, of row 166, Fluoxastrobin, the date is replaced by ‘31 July 2022’;

                        (20)

                        in the sixth column, expiration of approval, of row 167, Paecilomyces lilacinus strain 251, the date is replaced by ‘31 July 2022’;

                        (21)

                        in the sixth column, expiration of approval, of row 168, Prothioconazole, the date is replaced by ‘31 July 2022’;

                        (22)

                        in the sixth column, expiration of approval, of row 217, Metazachlor, the date is replaced by ‘31 July 2022’;

                        (23)

                        in the sixth column, expiration of approval, of row 219, Aluminium ammonium sulphate, the date is replaced by ‘31 August 2022’;

                        (24)

                        in the sixth column, expiration of approval, of row 220, Aluminium silicate, the date is replaced by ‘31 August 2022’;

                        (25)

                        in the sixth column, expiration of approval, of row 224, Calcium carbonate, the date is replaced by ‘31 August 2022’;

                        (26)

                        in the sixth column, expiration of approval, of row 225, Carbon dioxide, the date is replaced by ‘31 August 2022’;

                        (27)

                        in the sixth column, expiration of approval, of row 228, Extract from tea tree, the date is replaced by ‘31 August 2022’;

                        (28)

                        in the sixth column, expiration of approval, of row 229, Fat distillation residues, the date is replaced by ‘31 August 2022’;

                        (29)

                        in the sixth column, expiration of approval, of row 230, Fatty acids C7 to C20, the date is replaced by ‘31 August 2022’;

                        (30)

                        in the sixth column, expiration of approval, of row 232, Gibberellic acid, the date is replaced by ‘31 August 2022’;

                        (31)

                        in the sixth column, expiration of approval, of row 233, Gibberellins, the date is replaced by ‘31 August 2022’;

                        (32)

                        in the sixth column, expiration of approval, of row 234, Hydrolysed proteins, the date is replaced by ‘31 August 2022’;

                        (33)

                        in the sixth column, expiration of approval, of row 235, Iron sulphate, the date is replaced by ‘31 August 2022’;

                        (34)

                        in the sixth column, expiration of approval, of row 242, Plant oils/rape seed oil, the date is replaced by ‘31 August 2022’;

                        (35)

                        in the sixth column, expiration of approval, of row 244, Potassium hydrogen carbonate, the date is replaced by ‘31 August 2022’;

                        (36)

                        in the sixth column, expiration of approval, of row 247, Quartz sand, the date is replaced by ‘31 August 2022’;

                        (37)

                        in the sixth column, expiration of approval, of row 248, Fish oil, the date is replaced by ‘31 August 2022’;

                        (38)

                        in the sixth column, expiration of approval, of row 249, Repellents by smell of animal or plant origin/ sheep fat, the date is replaced by ‘31 August 2022’;

                        (39)

                        in the sixth column, expiration of approval, of row 255, Straight Chain Lepidopteran Pheromones, the date is replaced by ‘31 August 2022’;

                        (40)

                        in the sixth column, expiration of approval, of row 263, Cymoxanil, the date is replaced by ‘31 August 2022’;

                        (41)

                        in the sixth column, expiration of approval, of row 268, Tebuconazole, the date is replaced by ‘31 August 2022’;

                        (42)

                        in the sixth column, expiration of approval, of row 257, Urea, the date is replaced by ‘31 August 2022’;

                        (43)

                        in the sixth column, expiration of approval, of row 298, Heptamaloxyloglucan, the date is replaced by ‘31 May 2022’;

                        (44)

                        in the sixth column, expiration of approval, of row 354, Flurochloridone, the date is replaced by ‘31 May 2022’.


title: Commission Implementing Regulation (EU) 2021/1446 of 3 September 2021 correcting Implementing Regulations (EU) No 540/2011 and (EU) No 563/2014 as regards the CAS number of the basic substance chitosan hydrochloride (Text with EEA relevance)

text:
                  6.9.2021

                  EN

                  Official Journal of the European Union

                  L 313/9

         COMMISSION IMPLEMENTING REGULATION (EU) 2021/1446
         of 3 September 2021
         correcting Implementing Regulations (EU) No 540/2011 and (EU) No 563/2014 as regards the CAS number of the basic substance chitosan hydrochloride
         (Text with EEA relevance)
         THE EUROPEAN COMMISSION,
         Having regard to the Treaty on the Functioning of the European Union,
         Having regard to Regulation (EC) No 1107/2009 of the European Parliament and of the Council of 21 October 2009 concerning the placing of plant protection products on the market and repealing Council Directives 79/117/EEC and 91/414/EEC (1), and in particular Article 23(5) in conjunction with Article 13(2) and Article 78(2) thereof,
         Whereas:

                     (1)

                     Commission Implementing Regulation (EU) No 563/2014 (2) approved the basic substance chitosan hydrochloride and included it in the Annex to Commission Implementing Regulation (EU) No 540/2011 (3).

                     (2)

                     After Implementing Regulation (EU) No 563/2014 entered into force, an error was noted concerning the CAS number (Chemical Abstracts Number of the American Chemical Society) used for the basic substance chitosan hydrochloride in the Annexes to Implementing Regulation (EU) No 563/2014.

                     (3)

                     The CAS number is a unique chemical substance identifier, which is also used for identification of an active substance used in plant protection; it is used as reference for the purpose of trade and regulatory activities for chemicals globally and not limited to pesticidal substances.

                     (4)

                     The column on common name and identification numbers mentions ‘Chitosan hydrochloride CAS no: 9012-76-4’. However, the CAS number 9012-76-4 is assigned to the substance chitosan, while chitosan hydrochloride has the CAS number 70694-72-3. Therefore, as confusion about the substance identity may arise in chemicals management and trade, a correction of the CAS number mentioned in Implementing Regulation (EU) No 563/2014 and consequently in Implementing Regulation (EU) No 540/2011 is necessary.

                     (5)

                     For reasons of clarity, it is appropriate to replace Annex I to Implementing Regulation (EU) No 563/2014 and the relevant entry in Part C of the Annex to Implementing Regulation (EU) No 540/2011.

                     (6)

                     In the interest of clarity and legal certainty for economic operators and enforcement authorities, this Regulation should enter into force as a matter of urgency.

                     (7)

                     The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed,

               HAS ADOPTED THIS REGULATION:

            Article 1
            Correction to Implementing Regulation (EU) No 563/2014
            Annex I to Implementing Regulation (EU) No 563/2014 is corrected in accordance with Annex I to this Regulation.

            Article 2
            Correction to Implementing Regulation (EU) No 540/2011
            The Annex to Implementing Regulation (EU) No 540/2011 is corrected in accordance with Annex II to this Regulation.

            Article 3

                  Entry into force

            This Regulation shall enter into force on the day of its publication in the Official Journal of the European Union.

            This Regulation shall be binding in its entirety and directly applicable in all Member States.
            Done at Brussels, 3 September 2021.

                  For the Commission

                  The President

               Ursula VON DER LEYEN

            (1)  OJ L 309, 24.11.2009, p. 1.

            (2)  Commission Implementing Regulation (EU) No 563/2014 of 23 May 2014 approving the basic substance chitosan hydrochloride in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending Commission Implementing Regulation (EU) No 540/2011 (OJ L 156, 24.5.2014, p. 5).

            (3)  Commission Implementing Regulation (EU) No 540/2011 of 25 May 2011 implementing Regulation (EC) No 1107/2009 of the European Parliament and of the Council as regards the list of approved active substances (OJ L 153, 11.6.2011, p. 1).

            ANNEX I
            Annex I to Implementing Regulation (EU) No 563/2014 is replaced by the following:

                           ‘Common Name, Identification Numbers

                           IUPAC Name

                           Purity (1)

                           Date of approval

                           Specific provisions

                           Chitosan hydrochloride
                           CAS No: 70694-72-3

                           Not applicable

                           European Pharmacopeia
                           Max. content of heavy metals: 40 ppm

                           1 July 2014

                           Chitosan hydrochloride shall comply with Regulation (EC) No 1069/2009 of the European Parliament and of the Council (2) and Commission Regulation (EU) No 142/2011 (3).
                           Chitosan hydrochloride may be used in accordance with specific conditions included in the conclusions of the review report on chitosan hydrochloride (SANCO/12388/2013) and in particular Appendices I and II thereto, as finalised in the Standing Committee on the Food Chain and Animal Health on 20 March 2014.’

               (1)  Further details on identity, specification and manner of use of basic substance are provided in the review report.

               (2)  OJ L 300, 14.11.2009, p. 1.

               (3)  OJ L 54, 26.2.2011, p. 1.

            ANNEX II
            In Part C of the Annex to Implementing Regulation (EU) No 540/2011, entry 2 on chitosan hydrochloride is replaced by the following:

                           No

                           Common Name, Identification Numbers

                           IUPAC Name

                           Purity (1)

                           Date of approval

                           Specific provisions

                           ‘2

                           Chitosan hydrochloride
                           CAS No: 70694-72-3

                           Not applicable

                           European Pharmacopeia
                           Max. content of heavy metals: 40 ppm

                           1 July 2014

                           Chitosan hydrochloride shall comply with Regulation (EC) No 1069/2009 and Regulation (EU) No 142/2011.
                           Chitosan hydrochloride may be used in accordance with specific conditions included in the conclusions of the review report on chitosan hydrochloride (SANCO/12388/2013) and in particular Appendices I and II thereto, as finalised in the Standing Committee on the Food Chain and Animal Health on 20 March 2014.’

               (1)  Further details on identity, specification and manner of use of basic substance are provided in the review report.


title: Commission Implementing Regulation (EU) 2021/1447 of 3 September 2021 amending Implementing Regulation (EU) 2020/1534 imposing a definitive anti-dumping duty on imports of certain prepared or preserved citrus fruits (namely mandarins, etc.) originating in the People’s Republic of China following an expiry review pursuant to Article 11(2) of Regulation (EU) 2016/1036 of the European Parliament and of the Council

text:
                  6.9.2021

                  EN

                  Official Journal of the European Union

                  L 313/13

         COMMISSION IMPLEMENTING REGULATION (EU) 2021/1447
         of 3 September 2021
         amending Implementing Regulation (EU) 2020/1534 imposing a definitive anti-dumping duty on imports of certain prepared or preserved citrus fruits (namely mandarins, etc.) originating in the People’s Republic of China following an expiry review pursuant to Article 11(2) of Regulation (EU) 2016/1036 of the European Parliament and of the Council
         THE EUROPEAN COMMISSION,
         Having regard to the Treaty on the Functioning of the European Union,
         Having regard to Regulation (EU) 2016/1036 of the European Parliament and of the Council of 8 June 2016 on protection against dumped imports from countries not members of the European Union (1), and in particular Article 14(1) thereof,
         Whereas:

                     (1)

                     Imports of certain prepared or preserved citrus fruits (namely mandarins, etc.) originating in the People’s Republic of China are subject to a definitive anti-dumping duty, imposed by Commission Implementing Regulation (EU) 2020/1534 (2).

                     (2)

                     Toyoshima Share Yidu Foods Co., Ltd (3), TARIC (4) additional code A889, a company located in the People’s Republic of China whose exports to the Union of certain prepared or preserved citrus fruits (namely mandarins, etc.) are subject to the anti-dumping duty of 499,6 EUR/Tonne net product weight informed the Commission that as of 22 January 2008 it had changed its denomination as ‘Hubei Fomdas Foods Co., Ltd, Yidu, Hubei’.

                     (3)

                     The company, following the change of its name, requested on 31 March 2021 the Commission to confirm that the change of name does not affect the right of the company to benefit from the duty rate for cooperating exporting producers not included in the sample applied to it under its previous name. The company specifically clarified that it requests that the name change take effect as from the date of its request to the Commission, that is as from 31 March 2021.

                     (4)

                     The Commission examined the information supplied and concluded that the change of name was properly registered with the relevant authorities and did not result in any new relationship with other groups of companies, which were not investigated by the Commission. Accordingly, this change of name does not affect the findings of Implementing Regulation (EU) 2020/1534 and in particular the anti-dumping duty rate applicable to it.

                     (5)

                     Given the considerations in the above recital, the Commission considered it appropriate to amend Implementing Regulation (EU) 2020/1534 to reflect the changed name of the company previously attributed to additional TARIC code A889.

                     (6)

                     The measures provided for in this Regulation are in accordance with the opinion of the Committee established by Article 15(1) of Regulation (EU) 2016/1036.

               HAS ADOPTED THIS REGULATION:

            Article 1

               1.   The Annex of Implementing Regulation (EU) 2020/1534 is amended as follows:

                  ‘Toyoshima Share Yidu Foods Co.’

               Is replaced by

                  ‘Hubei Fomdas Foods Co., Ltd, Yidu, Hubei’.

               2.   TARIC additional code A889 previously attributed to Toyoshima Share Yidu Foods Co., Ltd, shall apply to Hubei Fomdas Foods Co., Ltd, Yidu, Hubei as of 31 March 2021. Any definitive duty paid on imports of products manufactured by Hubei Fomdas Foods Co., Ltd, Yidu, Hubei in excess of the anti-dumping duty established in Article 1(2) of Implementing Regulation (EU) 2020/1534 as regards Toyoshima Share Yidu Foods Co shall be repaid or remitted in accordance with the applicable customs legislation.

            Article 2
            This Regulation shall enter into force on the day following that of its publication in the Official Journal of the European Union.

            This Regulation shall be binding in its entirety and directly applicable in all Member States.
            Done at Brussels, 3 September 2021.

                  For the Commission

                  The President

               Ursula VON DER LEYEN

            (1)  OJ L 176, 30.6.2016, p. 21.

            (2)  Commission Implementing Regulation (EU) 2020/1534 of 21 October 2020 imposing a definitive anti-dumping duty on imports of certain prepared or preserved citrus fruits (namely mandarins, etc.) originating in the People’s Republic of China following an expiry review pursuant to Article 11(2) of Regulation (EU) 2016/1036 of the European Parliament and of the Council (OJ L 351, 22.10.2020, p.2).

            (3)  This company is listed in the Annex of Implementing Regulation (EU) 2020/1534 as a cooperating exporting producer not included in the sample.

            (4)  The Integrated Tariff of the European Union.


title: Commission Implementing Regulation (EU) 2021/1448 of 3 September 2021 renewing the approval of the low-risk active substance calcium carbonate in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (Text with EEA relevance)

text:
                  6.9.2021

                  EN

                  Official Journal of the European Union

                  L 313/15

         COMMISSION IMPLEMENTING REGULATION (EU) 2021/1448
         of 3 September 2021
         renewing the approval of the low-risk active substance calcium carbonate in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011
         (Text with EEA relevance)
         THE EUROPEAN COMMISSION,
         Having regard to the Treaty on the Functioning of the European Union,
         Having regard to Regulation (EC) No 1107/2009 of the European Parliament and of the Council of 21 October 2009 concerning the placing of plant protection products on the market and repealing Council Directives 79/117/EEC and 91/414/EEC (1), and in particular Article 20(1) in conjunction with Article 22(1) thereof,
         Whereas:

                     (1)

                     Commission Directive 2008/127/EC (2) included calcium carbonate as an active substance in Annex I to Council Directive 91/414/EEC (3).

                     (2)

                     Active substances included in Annex I to Directive 91/414/EEC are deemed to have been approved under Regulation (EC) No 1107/2009 and are listed in Part A of the Annex to Commission Implementing Regulation (EU) No 540/2011 (4).

                     (3)

                     The approval of the active substance calcium carbonate, as set out in Part A of the Annex to Implementing Regulation (EU) No 540/2011, expires on 31 August 2022.

                     (4)

                     An application for the renewal of the approval of the active substance calcium carbonate was submitted in accordance with Article 1 of Commission Implementing Regulation (EU) No 844/2012 (5) within the time period provided for in that Article.

                     (5)

                     The applicant submitted the supplementary dossiers required in accordance with Article 6 of Implementing Regulation (EU) No 844/2012. The application was found to be complete by the rapporteur Member State.

                     (6)

                     The rapporteur Member State prepared a draft renewal assessment report in consultation with the co-rapporteur Member State and submitted it to the European Food Safety Authority (‘the Authority’) and the Commission on 23 October 2019. The Authority made the supplementary summary dossier available to the public. The Authority also circulated the draft renewal assessment report to the applicant and to the Member States for comments and launched a public consultation on it. The Authority forwarded the comments received to the Commission.

                     (7)

                     On 9 February 2021, the Authority communicated to the Commission its conclusion (6) on whether calcium carbonate can be expected to meet the approval criteria provided for in Article 4 of Regulation (EC) No 1107/2009.

                     (8)

                     The Commission presented a renewal report and a draft Regulation regarding calcium carbonate to the Standing Committee on Plants, Animals, Food and Feed on 19 May 2021.

                     (9)

                     The Commission invited the applicant to submit its comments on the conclusion of the Authority and, in accordance with the third paragraph of Article 14(1) of Implementing Regulation (EU) No 844/2012, on the renewal report. The applicant submitted its comments, which have been carefully examined.

                     (10)

                     It has been established with respect to one or more representative uses of at least one plant protection product containing the active substance calcium carbonate that the approval criteria provided for in Article 4 of Regulation (EC) No 1107/2009 are satisfied.

                     (11)

                     The risk assessment for the renewal of the approval of the active substance calcium carbonate is based on a limited number of representative uses, which however do not restrict the uses for which plant protection products containing calcium carbonate may be authorised. It is therefore appropriate not to maintain the restriction to use as a repellent.

                     (12)

                     The Commission further considers that calcium carbonate is a low-risk active substance pursuant to Article 22 of Regulation (EC) No 1107/2009. Calcium carbonate is not a substance of concern and fulfils the conditions set in point 5.1 of Annex II to Regulation (EC) No 1107/2009. It is therefore appropriate to renew the approval of calcium carbonate as a low-risk substance.

                     (13)

                     Implementing Regulation (EU) No 540/2011 should therefore be amended accordingly.

                     (14)

                     Commission Implementing Regulation (EU) 2021/745 (7) extended the approval period of calcium carbonate until 31 August 2022 in order to allow the renewal process to be completed before the expiry of the approval period of that active substance. However, given that a decision on renewal has been taken ahead of the expiry of that extended approval period, this Regulation should start to apply earlier than that date.

                     (15)

                     The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed,

               HAS ADOPTED THIS REGULATION:

            Article 1
            Renewal of the approval of the active substance
            The approval of the active substance calcium carbonate, as specified in Annex I, as low risk substance is renewed.

            Article 2
            Amendments to Implementing Regulation (EU) No 540/2011
            The Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with Annex II to this Regulation.

            Article 3
            Entry into force and date of application
            This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.
            It shall apply from 1 November 2021.

            This Regulation shall be binding in its entirety and directly applicable in all Member States.
            Done at Brussels, 3 September 2021.

                  For the Commission

                  The President

               Ursula VON DER LEYEN

            (1)  OJ L 309, 24.11.2009, p. 1.

            (2)  Commission Directive 2008/127/EC of 18 December 2008 amending Council Directive 91/414/EEC to include several active substances (OJ L 344, 20.12.2008, p. 89).

            (3)  Council Directive 91/414/EEC of 15 July 1991 concerning the placing of plant protection products on the market (OJ L 230, 19.8.1991, p. 1).

            (4)  Commission Implementing Regulation (EU) No 540/2011 of 25 May 2011 implementing Regulation (EC) No 1107/2009 of the European Parliament and of the Council as regards the list of approved active substances (OJ L 153, 11.6.2011, p. 1).

            (5)  Commission Implementing Regulation (EU) No 844/2012 of 18 September 2012 setting out the provisions necessary for the implementation of the renewal procedure for active substances, as provided for in Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market (OJ L 252, 19.9.2012, p. 26).

            (6)  EFSA Journal 2021;19(4):6500 Available online: www.efsa.europa.eu

            (7)  Commission Implementing Regulation (EU) 2021/745 of 6 May 2021 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances aluminium ammonium sulphate, aluminium silicate, beflubutamid, benthiavalicarb, bifenazate, boscalid, calcium carbonate, captan, carbon dioxide, cymoxanil, dimethomorph, ethephon, extract from tea tree, famoxadone, fat distilation residues, fatty acids C7 to C20, flumioxazine, fluoxastrobin, flurochloridone, folpet, formetanate, gibberellic acid, gibberellins, heptamaloxyloglucan, hydrolysed proteins, iron sulphate, metazachlor, metribuzin, milbemectin, Paecilomyces lilacinus strain 251, phenmedipham, phosmet, pirimiphos-methyl, plant oils/rape seed oil, potassium hydrogen carbonate, propamocarb, prothioconazole, quartz sand, fish oil, repellents by smell of animal or plant origin/sheep fat, S-metolachlor, Straight Chain Lepidopteran Pheromones, tebuconazole and urea (OJ L 160, 7.5.2021, p. 89).

            ANNEX I

                           Common Name, Identification Numbers

                           IUPAC Name

                           Purity  (1)

                           Date of approval

                           Expiration of approval

                           Specific provisions

                        Calcium carbonate
                        CAS No 471-34-1
                        CIPAC No 843

                        IUPAC name: Calcium carbonate

                        950 g/kg

                           1 November 2021

                           31 October 2036

                        For the implementation of the uniform principles, as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the renewal report on calcium carbonate, and in particular Appendices I and II thereto, shall be taken into account.

               (1)  Further details on the identity and the specification of the active substance are provided in the renewal report.

            ANNEX II
            The Annex to Commission Implementing Regulation (EU) No 540/2011 is amended as follows:

                        (1)

                        in Part A, entry 224 on calcium carbonate is deleted;

                        (2)

                        in Part D, the following entry is added:

                                       Number

                                       Common Name, Identification Numbers

                                       IUPAC Name

                                       Purity

                                       Date of approval

                                       Expiration of approval

                                       Specific provisions

                                    ‘31

                                    Calcium carbonate
                                    CAS No 471-34-1
                                    CIPAC No 843

                                    IUPAC name: Calcium carbonate

                                    950 g/kg

                                    1 November 2021

                                       31 October 2036

                                    For the implementation of the uniform principles, as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the renewal report on calcium carbonate, and in particular Appendices I and II thereto, shall be taken into account.’


title: Commission Implementing Regulation (EU) 2021/1449 of 3 September 2021 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 2-phenylphenol (including its salts such as the sodium salt), 8-hydroxyquinoline, amidosulfuron, bifenox, chlormequat, chlorotoluron, clofentezine, clomazone, cypermethrin, daminozide, deltamethrin, dicamba, difenoconazole, diflufenican, dimethachlor, etofenprox, fenoxaprop-P, fenpropidin, fludioxonil, flufenacet, fosthiazate, indoxacarb, lenacil, MCPA, MCPB, nicosulfuron, paraffin oils, paraffin oil, penconazole, picloram, propaquizafop, prosulfocarb, quizalofop-P-ethyl, quizalofop-P-tefuryl, sulphur, tetraconazole, tri-allate, triflusulfuron and tritosulfuron (Text with EEA relevance)

text:
                  6.9.2021

                  EN

                  Official Journal of the European Union

                  L 313/20

         COMMISSION IMPLEMENTING REGULATION (EU) 2021/1449
         of 3 September 2021
         amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 2-phenylphenol (including its salts such as the sodium salt), 8-hydroxyquinoline, amidosulfuron, bifenox, chlormequat, chlorotoluron, clofentezine, clomazone, cypermethrin, daminozide, deltamethrin, dicamba, difenoconazole, diflufenican, dimethachlor, etofenprox, fenoxaprop-P, fenpropidin, fludioxonil, flufenacet, fosthiazate, indoxacarb, lenacil, MCPA, MCPB, nicosulfuron, paraffin oils, paraffin oil, penconazole, picloram, propaquizafop, prosulfocarb, quizalofop-P-ethyl, quizalofop-P-tefuryl, sulphur, tetraconazole, tri-allate, triflusulfuron and tritosulfuron
         (Text with EEA relevance)
         THE EUROPEAN COMMISSION,
         Having regard to the Treaty on the Functioning of the European Union,
         Having regard to Regulation (EC) No 1107/2009 of the European Parliament and of the Council of 21 October 2009 concerning the placing of plant protection products on the market and repealing Council Directives 79/117/EEC and 91/414/EEC (1), and in particular Article 17, first paragraph, thereof,
         Whereas:

                     (1)

                     Part A of the Annex to Commission Implementing Regulation (EU) No 540/2011 (2) sets out the active substances deemed to have been approved under Regulation (EC) No 1107/2009.

                     (2)

                     Commission Implementing Regulation (EU) 2020/1511 (3) extended the approval period of the active substances chlorotoluron, clomazone, cypermethrin, daminozide, deltamethrin, fludioxonil, flufenacet, fosthiazate, indoxacarb, MCPA, MCPB, and prosulfocarb until 31 October 2021, of the active substance tritosulfuron until 30 November 2021 and of the active substances amidosulfuron, bifenox, clofentezine, dicamba, difenoconazole, diflufenican, fenoxaprop-P, fenpropidin, lenacil, nicosulfuron, paraffin oils, picloram, sulphur and triflusulfuron until 31 December 2021. Commission Implementing Regulation (EU) 2020/2104 (4) extended the approval period of the active substance paraffin oil until 31 December 2021. Commission Implementing Regulation (EU) 2017/555 (5) extended the approval period of the active substances chlormequat, propaquizafop and quizalofop-P-ethyl until 30 November 2021 and of the active substances 2-phenylphenol (including its salts such as the sodium salt), dimethachlor, etofenprox, penconazole, tetraconazole and tri-allate until 31 December 2021. Commission Implementing Regulation (EU) 2017/1530 (6) extended the approval period of the active substance quizalofop-P-tefuryl until 30 November 2021.

                     (3)

                     The approval of the active substance 8-hydroxyquinoline is set to expire on 31 December 2021 in accordance with Commission Implementing Regulation (EU) No 993/2011 (7).

                     (4)

                     Applications for the renewal of the approval of those substances were submitted in accordance with Commission Implementing Regulation (EU) No 844/2012 (8).

                     (5)

                     Due to the fact that the assessment of those active substances has been delayed for reasons beyond the control of the applicants, the approvals of those active substances are likely to expire before a decision has been taken on their renewal. It is therefore necessary to extend their approval periods.

                     (6)

                     In addition, an extension of the approval period is required for the active substances 2-phenylphenol (including its salts such as the sodium salt), 8-hydroxyquinoline, amidosulfuron, clofentezine, clomazone, daminozide, fenoxaprop-P, fludioxonil, flufenacet, lenacil, triflusulfuron and tritosulfuron to provide the time necessary to carry out an assessment relating to endocrine disrupting properties of those active substances in accordance with the procedure set out in Articles 13 and 14 of Implementing Regulation (EU) No 844/2012.

                     (7)

                     As regards cases where the Commission is to adopt a Regulation providing that the approval of an active substance referred to in the Annex to this Regulation is not renewed because the approval criteria are not satisfied, the Commission is to set the expiry date at the same date as before this Regulation or at the date of the entry into force of the Regulation providing that the approval of the active substance is not renewed, whichever date is later. As regards cases where the Commission is to adopt a Regulation providing for the renewal of an active substance referred to in the Annex to this Regulation, the Commission will endeavour to set, as appropriate under the circumstances, the earliest possible application date.

                     (8)

                     Implementing Regulation (EU) No 540/2011 should therefore be amended accordingly.

                     (9)

                     The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed,

               HAS ADOPTED THIS REGULATION:

            Article 1
            The Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation.

            Article 2
            This Regulation shall enter into force on the third day following that of its publication in the Official Journal of the European Union.

            This Regulation shall be binding in its entirety and directly applicable in all Member States.
            Done at Brussels, 3 September 2021.

                  For the Commission

                  The President

               Ursula VON DER LEYEN

            (1)  OJ L 309, 24.11.2009, p. 1.

            (2)  Commission Implementing Regulation (EU) No 540/2011 of 25 May 2011 implementing Regulation (EC) No 1107/2009 of the European Parliament and of the Council as regards the list of approved active substances (OJ L 153, 11.6.2011, p. 1).

            (3)  Commission Implementing Regulation (EU) 2020/1511 of 16 October 2020 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances amidosulfuron, bifenox, chlorotoluron, clofentezine, clomazone, cypermethrin, daminozide, deltamethrin, dicamba, difenoconazole, diflufenican, fenoxaprop-P, fenpropidin, fludioxonil, flufenacet, fosthiazate, indoxacarb, lenacil, MCPA, MCPB, nicosulfuron, paraffin oils, picloram, prosulfocarb, sulphur, triflusulfuron and tritosulfuron (OJ L 344, 19.10.2020, p. 18).

            (4)  Commission Implementing Regulation (EU) 2020/2104 of 15 December 2020 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval period of the active substance paraffin oil (OJ L 425, 16.12.2020, p. 93).

            (5)  Commission Implementing Regulation (EU) 2017/555 of 24 March 2017 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of several active substances listed in Part B of the Annex to Implementing Regulation (EU) No 686/2012 (AIR IV renewal programme) (OJ L 80, 25.3.2017, p. 1).

            (6)  Commission Implementing Regulation (EU) 2017/1530 of 7 September 2017 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval period of the active substance quizalofop-p-tefuryl (OJ L 232, 8.9.2017, p. 4).

            (7)  Commission Implementing Regulation (EU) No 993/2011 of 6 October 2011 approving the active substance 8-hydroxyquinoline, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L 263, 7.10.2011, p. 1).

            (8)  Commission Implementing Regulation (EU) No 844/2012 of 18 September 2012 setting out the provisions necessary for the implementation of the renewal procedure for active substances, as provided for in Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market (OJ L 252, 19.9.2012, p. 26).

            ANNEX
            Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows:

                        (1)

                        in the sixth column, expiration of approval, of row 18, 8-hydroxyquinoline, the date is replaced by ‘31 December 2022’;

                        (2)

                        in the sixth column, expiration of approval, of row 40, Deltamethrin, the date is replaced by ‘31 October 2022’;

                        (3)

                        in the sixth column, expiration of approval, of row 65, Flufenacet, the date is replaced by ‘31 October 2022’;

                        (4)

                        in the sixth column, expiration of approval, of row 69, Fosthiazate, the date is replaced by ‘31 October 2022’;

                        (5)

                        in the sixth column, expiration of approval, of row 102, Chlorotoluron, the date is replaced by ‘31 October 2022’;

                        (6)

                        in the sixth column, expiration of approval, of row 103, Cypermethrin, the date is replaced by ‘31 October 2022’;

                        (7)

                        in the sixth column, expiration of approval, of row 104, Daminozide, the date is replaced by ‘31 October 2022’;

                        (8)

                        in the sixth column, expiration of approval, of row 107, MCPA, the date is replaced by ‘31 October 2022’;

                        (9)

                        in the sixth column, expiration of approval, of row 108, MCPB, the date is replaced by ‘31 October 2022’;

                        (10)

                        in the sixth column, expiration of approval, of row 119, Indoxacarb, the date is replaced by ‘31 October 2022’;

                        (11)

                        in the sixth column, expiration of approval, of row 160, Prosulfocarb, the date is replaced by ‘31 October 2022’;

                        (12)

                        in the sixth column, expiration of approval, of row 161, Fludioxonil, the date is replaced by ‘31 October 2022’;

                        (13)

                        in the sixth column, expiration of approval, of row 162, Clomazone, the date is replaced by ‘31 October 2022’;

                        (14)

                        in the sixth column, expiration of approval, of row 169, Amidosulfuron, the date is replaced by ‘31 December 2022’;

                        (15)

                        in the sixth column, expiration of approval, of row 170, Nicosulfuron, the date is replaced by ‘31 December 2022’;

                        (16)

                        in the sixth column, expiration of approval, of row 171, Clofentezine, the date is replaced by ‘31 December 2022’;

                        (17)

                        in the sixth column, expiration of approval, of row 172, Dicamba, the date is replaced by ‘31 December 2022’;

                        (18)

                        in the sixth column, expiration of approval, of row 173, Difenoconazole, the date is replaced by ‘31 December 2022’;

                        (19)

                        in the sixth column, expiration of approval, of row 176, Lenacil, the date is replaced by ‘31 December 2022’;

                        (20)

                        in the sixth column, expiration of approval, of row 178, Picloram, the date is replaced by ‘31 December 2022’;

                        (21)

                        in the sixth column, expiration of approval, of row 180, Bifenox, the date is replaced by ‘31 December 2022’;

                        (22)

                        in the sixth column, expiration of approval, of row 181, Diflufenican, the date is replaced by ‘31 December 2022’;

                        (23)

                        in the sixth column, expiration of approval, of row 182, Fenoxaprop-P, the date is replaced by ‘31 December 2022’;

                        (24)

                        in the sixth column, expiration of approval, of row 183, Fenpropidin, the date is replaced by ‘31 December 2022’;

                        (25)

                        in the sixth column, expiration of approval, of row 186, Tritosulfuron, the date is replaced by ‘30 November 2022’;

                        (26)

                        in the sixth column, expiration of approval, of row 276, Chlormequat, the date is replaced by ‘30 November 2022’;

                        (27)

                        in the sixth column, expiration of approval, of row 278, Propaquizafop, the date is replaced by ‘30 November 2022’;

                        (28)

                        in the sixth column, expiration of approval, of row 279, Quizalofop-P-ethyl and Quizalofop-P-tefuryl, the date is replaced by ‘30 November 2022’;

                        (29)

                        in the sixth column, expiration of approval, of row 284, Dimethachlor, the date is replaced by ‘31 December 2022’;

                        (30)

                        in the sixth column, expiration of approval, of row 285, Etofenprox, the date is replaced by ‘31 December 2022’;

                        (31)

                        in the sixth column, expiration of approval, of row 287, Penconazole, the date is replaced by ‘31 December 2022’;

                        (32)

                        in the sixth column, expiration of approval, of row 288, Tri-allate, the date is replaced by ‘31 December 2022’;

                        (33)

                        in the sixth column, expiration of approval, of row 289, Triflusulfuron, the date is replaced by ‘31 December 2022’;

                        (34)

                        in the sixth column, expiration of approval, of row 292, Sulphur, the date is replaced by ‘31 December 2022’;

                        (35)

                        in the sixth column, expiration of approval, of row 293, Tetraconazole, the date is replaced by ‘31 December 2022’;

                        (36)

                        in the sixth column, expiration of approval, of row 294, Paraffin oils, the date is replaced by ‘31 December 2022’;

                        (37)

                        in the sixth column, expiration of approval, of row 295, Paraffin oil, the date is replaced by ‘31 December 2022’;

                        (38)

                        in the sixth column, expiration of approval, of row 299, 2-phenylphenol (including its salts such as the sodium salt), the date is replaced by ‘31 December 2022’.


title: Commission Implementing Regulation (EU) 2021/1450 of 3 September 2021 amending Implementing Regulation (EU) No 540/2011 as regards the approval periods of the active substances acrinathrin and prochloraz (Text with EEA relevance)

text:
                  6.9.2021

                  EN

                  Official Journal of the European Union

                  L 313/25

         COMMISSION IMPLEMENTING REGULATION (EU) 2021/1450
         of 3 September 2021
         amending Implementing Regulation (EU) No 540/2011 as regards the approval periods of the active substances acrinathrin and prochloraz
         (Text with EEA relevance)
         THE EUROPEAN COMMISSION,
         Having regard to the Treaty on the Functioning of the European Union,
         Having regard to Regulation (EC) No 1107/2009 of the European Parliament and of the Council of 21 October 2009 concerning the placing of plant protection products on the market and repealing Council Directives 79/117/EEC and 91/414/EEC (1), and in particular the first paragraph of Article 17 thereof,
         Whereas:

                     (1)

                     Part A of the Annex to Commission Implementing Regulation (EU) No 540/2011 (2) sets out the active substances deemed to have been approved under Regulation (EC) No 1107/2009.

                     (2)

                     The approval periods of the active substances acrinathrin and prochloraz were extended from 31 December 2021 until 31 December 2023 by Commission Implementing Regulation (EU) 2019/291 (3).

                     (3)

                     Applications for the renewal of the approval of the active substances concerned were submitted in accordance with Article 1 of Commission Implementing Regulation (EU) No 844/2012 (4). However, for the active substances acrinathrin and prochloraz, the applicants have confirmed that they no longer support the applications for renewal of approval.

                     (4)

                     In view of the aim of the first paragraph of Article 17 of Regulation (EC) No 1107/2009, the extensions of the approval periods of those active substances, provided for by Implementing Regulation (EU) 2019/291, are no longer justified. It is therefore appropriate to provide that the approvals of acrinathrin and prochloraz expire at the dates they would have expired without those extensions.

                     (5)

                     Implementing Regulation (EU) No 540/2011 should therefore be amended accordingly.

                     (6)

                     The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed,

               HAS ADOPTED THIS REGULATION:

            Article 1
            The Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation.

            Article 2
            This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.

            This Regulation shall be binding in its entirety and directly applicable in all Member States.
            Done at Brussels, 3 September 2021.

                  For the Commission

                  The President

               Ursula VON DER LEYEN

            (1)  OJ L 309, 24.11.2009, p. 1.

            (2)  Commission Implementing Regulation (EU) No 540/2011 of 25 May 2011 implementing Regulation (EC) No 1107/2009 of the European Parliament and of the Council as regards the list of approved active substances (OJ L 153, 11.6.2011, p. 1).

            (3)  Commission Implementing Regulation (EU) 2019/291 of 19 February 2019 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 1-naphthylacetamide, 1-naphthylacetic acid, acrinathrin, azoxystrobin, fluazifop p, fluroxypyr, imazalil, kresoxim-methyl, oxyfluorfen, prochloraz, prohexadione, spiroxamine, tefluthrin and terbuthylazine (OJ L 48, 20.2.2019, p. 17).

            (4)  Commission Implementing Regulation (EU) No 844/2012 of 18 September 2012 setting out the provisions necessary for the implementation of the renewal procedure for active substances, as provided for in Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market (OJ L 252, 19.9.2012, p. 26).

            ANNEX
            Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows:

                        (1)

                        in the sixth column, expiration of approval, of row 19, acrinathrin, the date is replaced by ‘31 December 2021’;

                        (2)

                        in the sixth column, expiration of approval, of row 20, prochloraz, the date is replaced by ‘31 December 2021’.